Form 4 for INSM INSMED Inc
Accepted 2023-01-12 00:00:00 ET · period of report 2023-01-10 · accession 0001628280-23-000958 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-12 | 2023-01-10 | INSM | Bonstein Sara | CFO | S - Sale | $18.12 | -2,857 | 66.0K | -4% | -$51.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-10 | S | D | 2,857 | $18.12 | 66,031 | D | — | — | (F2) This is the weighted average sales price representing 2,857 shares sold at prices ranging from $18.03 to $18.19 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |